Wednesday, June 29, 2011

Avastin Supporters Testify At FDA!


AvastinAvastin

About a dozen women with breast cancer, some Tearful asked the food and Drug Administration Tuesday, the consent of the trade name Avastin for maintaining medication treatment of the disease. Witnesses at a hearing in f.d.a, women said that even if the clinical trials may not have shown any huge advantage of total treatment with medication, medicine, some women helps considerable and should be left for them. Read more

No comments:

Post a Comment